Dash Bio

Dash Bio is a pioneering force in biotechnology research, dedicated to accelerating drug development through innovative bioanalysis solutions. By integrating cutting-edge AI and robotics, Dash Bio delivers unparalleled assay quality and significantly faster turnaround times, up to 10x quicker than traditional industry standards. This advanced approach ensures seamless scalability from initial discovery phases through late-stage clinical studies.

Located at Primary: 56 Broad St, Boston, Massachusetts 02109, US, Dash Bio is transforming the landscape of clinical bioanalysis. The company’s focus on automation and technological advancement streamlines critical processes, reducing both costs and time to market while upholding the highest standards of quality and regulatory compliance. Dash Bio’s modern platform is designed to provide an intuitive experience, ensuring data flows effortlessly and efficiently.

Dash Bio is committed to enhancing customer outcomes and driving continuous improvement in bioanalytical processes. As a forward-thinking company, Dash Bio is setting new benchmarks in the industry, facilitating the faster delivery of life-changing drugs to market. We invite the management of Dash Bio to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.